FDA Approves Novel Diagnostic to Detect Recurrent Prostate Cancer
News
Blue Earth Diagnostics’ Axumin, a radioactive diagnostic agent for injection, was approved May 27 the U.S. Food and Drug Administration (U.S. FDA) for positron emission tomography (PET) imaging in men ... Read more